1. Home
  2. CRGX vs PBT Comparison

CRGX vs PBT Comparison

Compare CRGX & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • PBT
  • Stock Information
  • Founded
  • CRGX 2021
  • PBT 1980
  • Country
  • CRGX United States
  • PBT United States
  • Employees
  • CRGX N/A
  • PBT N/A
  • Industry
  • CRGX
  • PBT Oil & Gas Production
  • Sector
  • CRGX
  • PBT Energy
  • Exchange
  • CRGX Nasdaq
  • PBT Nasdaq
  • Market Cap
  • CRGX 621.4M
  • PBT 599.9M
  • IPO Year
  • CRGX 2023
  • PBT N/A
  • Fundamental
  • Price
  • CRGX $12.39
  • PBT $11.73
  • Analyst Decision
  • CRGX Strong Buy
  • PBT
  • Analyst Count
  • CRGX 6
  • PBT 0
  • Target Price
  • CRGX $31.80
  • PBT N/A
  • AVG Volume (30 Days)
  • CRGX 287.3K
  • PBT 194.3K
  • Earning Date
  • CRGX 11-12-2024
  • PBT 01-01-0001
  • Dividend Yield
  • CRGX N/A
  • PBT 4.63%
  • EPS Growth
  • CRGX N/A
  • PBT 25.21
  • EPS
  • CRGX N/A
  • PBT 0.78
  • Revenue
  • CRGX N/A
  • PBT $37,735,284.00
  • Revenue This Year
  • CRGX N/A
  • PBT N/A
  • Revenue Next Year
  • CRGX N/A
  • PBT N/A
  • P/E Ratio
  • CRGX N/A
  • PBT $15.12
  • Revenue Growth
  • CRGX N/A
  • PBT 25.46
  • 52 Week Low
  • CRGX $10.91
  • PBT $10.14
  • 52 Week High
  • CRGX $33.92
  • PBT $15.79
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 39.66
  • PBT 49.48
  • Support Level
  • CRGX $10.91
  • PBT $11.62
  • Resistance Level
  • CRGX $15.75
  • PBT $12.24
  • Average True Range (ATR)
  • CRGX 1.20
  • PBT 0.48
  • MACD
  • CRGX -0.11
  • PBT 0.09
  • Stochastic Oscillator
  • CRGX 30.08
  • PBT 74.13

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About PBT Permian Basin Royalty Trust

Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.

Share on Social Networks: